# KLA Tencor: portfolio, investments and team > KLA Tencor is a corporate vc based in United States. 2 investments on record, latest May 2017. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/kla-tencor (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # KLA Tencor Last cheque observed May 2017. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Quiet Corporate VC Series B Biotechnology Health Diagnostics Automotive Cheques on record **0%** of best year **0** **cheques in 12 months**, 2 on record Since the last cheque **3460** days **00** hrs **00** min **00** sec Median round **$10M** Rounds led **0 of 2** Exits **1 from the portfolio** Pitch KLA Tencor ## KLA Tencor highlights - 01 2 rounds on record - 02 Mostly Series B: 100% of its rounds - 03 1 exits from the portfolio ## What they do - **Type:** Corporate VC (from a list, unverified) - **Cheque size:** Not stated - **Sectors:** Biotechnology Health Diagnostics Automotive - **Based in:** United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **2 appearances** - **2017** 1 round - **May** **[Luxexcel](https://millionrounds.com/company/luxexcel)** BE · 3dprint **$10M** With 3 others - **2004** 1 round - **Apr** **[Molecular Imprints](https://millionrounds.com/company/molecular-imprints)** Series B · US **Undisclosed** With 5 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team We hold **1** person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## Exits from the portfolio Companies it backed that were later bought or listed **1 in all** **[Molecular Imprints](https://millionrounds.com/company/molecular-imprints)** Bought by [Canon](https://millionrounds.com/fund/canon) **Undisclosed** Apr 2014 An exit counts when it came after the firm's first round in the company. From historical deal records. ## The cheque Series B Median round joined **$10M** the round, not its cheque Led 0 of 2 rounds **0%** - **Sole investor:** Never alone - **Last cheque:** May 2017 - **Exits:** 1 from the portfolio Rounds by stage said on their site - Series B *1* Cheques by year Led Joined 2004 2017 **Pitching KLA Tencor?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Quick answers about KLA Tencor ### What does KLA Tencor invest in? KLA Tencor invests most often at Series B (100% of the rounds on record), in sectors such as Biotechnology, Health Diagnostics and Automotive. ### How active is KLA Tencor? 2 investments on record, 0 of them in the last 12 months. The most recent was in May 2017. ### What has KLA Tencor invested in recently? Its most recent investments on record: Luxexcel (Undisclosed round, May 2017). ### How big are KLA Tencor's cheques? The median round it joins is $10M. ### Is KLA Tencor investing now? No investments in the last 12 months; the latest was in May 2017. ### What kind of investor is KLA Tencor? KLA Tencor is a corporate VC based in United States. ### When was KLA Tencor founded? KLA Tencor was founded in 1976. ### Where does this information on KLA Tencor come from? From 1 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=kla-tencor) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=kla-tencor)